Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f57f5adc2a4aff9d5c989e9fdbefe18 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-507 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09 |
filingDate |
2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9873198807f79d87d9468148452b14a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5166a6530b11e6907bb21f01783608d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b93e755e934e9c5ae7f8e69a63337b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae5a360cbb9852ad68423eb2e30e4a0 |
publicationDate |
2006-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7011815-B2 |
titleOfInvention |
Diagnostic imaging contrast agents with extended blood retention |
abstract |
The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008022263-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394356-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012107249-A1 |
priorityDate |
1995-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |